cdn mobile
Internal cleansing program

LCPO to continue year-round series of drug tests

By: Futch Anthony Inso - CDN Digital | January 18,2023 - 05:10 PM

drug test police

On Wednesday afternoon, January 18, 2023, 88 police personnel from LCPO were subjected to drug testing. | contributed photo

LAPU-LAPU CITY, Cebu—The Lapu-Lapu City Police Office (LCPO) will continue its internal cleansing program, by conducting a series of drug tests whole year round.

This was confirmed by Police Colonel Elmer Lim, chief of the LCPO.

“Pirmi gyud na atong pag-conduct og drug test, in fact in the year 2022, naa tay 99.72 percent nga compliance sa atoang personnel,” Lim said.

Lim, however, is glad that none of his personnel tested positive in the series of drug tests that were conducted in 2022.

He also revealed that they failed to reach 100 percent compliance due to medical issues of some of his personnel.

“Ang katong wala kay wala man siya mag-100 percent, tungod kay medical issues no diin na-optional nalang pod sila,” he added.

On Wednesday afternoon, January 18, 2023, 88 police personnel from LCPO were subjected to drug testing.  Lim also submitted himself for drug test.

The drug test was conducted by the Scene of the Crime Operatives (SOCO).

/bmjo

READ MORE:

Rep. Chan gives aid to Ibo fire victims

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Lapu-Lapu news, LCPO, Police Colonel Elmer Lim
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.